Fibriant was founded in 2015 and is located in Leiden, The Netherlands. The Research and Development Facility is located in the Bioscience Park adjacent to the campus of the renowned University of Leiden. Our core activity is the manufacturing and characterization of specific variants of fibrinogen. Fibriant executes a hybrid business model: •we use the fibrinogen technology platform for internal product and lead development and •we support research and product development of others